Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions
出版年份 2021 全文链接
标题
Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions
作者
关键词
-
出版物
CNS DRUGS
Volume 35, Issue 11, Pages 1153-1161
出版商
Springer Science and Business Media LLC
发表日期
2021-10-16
DOI
10.1007/s40263-021-00864-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges
- (2021) Oriane Razakarivony et al. Translational Psychiatry
- EPA Guidance on Assessment of Negative Symptoms in Schizophrenia
- (2021) S. Galderisi et al. EUROPEAN PSYCHIATRY
- Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
- (2021) Stephen K. Brannan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses
- (2021) Armida Mucci et al. JAMA Psychiatry
- Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development
- (2021) Gregory P. Strauss et al. npj Schizophrenia
- Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study
- (2021) Christoph U. Correll et al. CNS SPECTRUMS
- Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention
- (2021) Felipe V. Gomes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Additional perspective on cariprazine and negative symptoms
- (2021) Joshua T. Kantrowitz EXPERT OPINION ON PHARMACOTHERAPY
- The Potential Role of Lumateperone—Something Borrowed? Something New?
- (2020) Joshua T. Kantrowitz JAMA Psychiatry
- Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
- (2020) Joshua T. Kantrowitz et al. NEUROPSYCHOPHARMACOLOGY
- A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
- (2020) Kenneth S. Koblan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of a trace amine-associated receptor 1 agonist RO 5263397 on ethanol-induced behavioral sensitization
- (2020) Ruyan Wu et al. BEHAVIOURAL BRAIN RESEARCH
- Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
- (2020) Joshua T. Kantrowitz CNS DRUGS
- Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation
- (2020) Rouba Kozak et al. Frontiers in Pharmacology
- Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
- (2020) Seetal Dodd et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise
- (2020) Ryan E. Lawrence et al. SCHIZOPHRENIA RESEARCH
- Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia
- (2019) Istvan Bitter et al. NEUROPSYCHOPHARMACOLOGY
- Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice
- (2019) Aleksander A. Aleksandrov et al. Frontiers in Pharmacology
- SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A UNIQUE, NON-D2 RECEPTOR MECHANISM OF ACTION
- (2019) Nina Dedic et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats
- (2019) Artem Dorotenko et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders
- (2019) Grazia Rutigliano et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice
- (2019) Aleksander A. Aleksandrov et al. NEUROREPORT
- New discoveries for an old drug: a review of recent olanzapine research
- (2019) Amir M Meftah et al. POSTGRADUATE MEDICINE
- Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
- (2018) Michael D. Schwartz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)
- (2018) A. Egerton et al. MOLECULAR PSYCHIATRY
- Role of trace amine-associated receptor 1 in nicotine’s behavioral and neurochemical effects
- (2018) Jian-Feng Liu et al. NEUROPSYCHOPHARMACOLOGY
- Characterization of Dopaminergic System in the Striatum of Young Adult Park2−/− Knockout Rats
- (2018) Jickssa M. Gemechu et al. Scientific Reports
- Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine
- (2018) Ilya Sukhanov et al. Frontiers in Pharmacology
- Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
- (2018) Stefano Espinoza et al. Frontiers in Pharmacology
- N -methyl- d -aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia
- (2018) Joshua T. Kantrowitz SCHIZOPHRENIA RESEARCH
- Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia
- (2018) Kimberly E. Vanover et al. NEUROPSYCHOPHARMACOLOGY
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
- (2017) Mark D. Berry et al. PHARMACOLOGY & THERAPEUTICS
- Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D2 Receptor Controls Cocaine’s Neurochemical Actions
- (2017) Aman Asif-Malik et al. Scientific Reports
- The effects of glycine on auditory mismatch negativity in schizophrenia
- (2017) Lisa-Marie Greenwood et al. SCHIZOPHRENIA RESEARCH
- Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms
- (2017) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine
- (2016) Joshua T. Kantrowitz et al. BRAIN
- Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- (2016) Anna Rickli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats
- (2016) Antonio Ferragud et al. NEUROPSYCHOPHARMACOLOGY
- Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications
- (2016) Yue Pei et al. Frontiers in Neuroscience
- High-throughput analysis of behavior for drug discovery
- (2015) Vadim Alexandrov et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers
- (2015) Anja Harmeier et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1
- (2015) Stefano Espinoza et al. NEUROPHARMACOLOGY
- Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
- (2015) Anna Rickli et al. NEUROPHARMACOLOGY
- TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
- (2015) Stefano Espinoza et al. NEUROPSYCHOPHARMACOLOGY
- Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
- (2015) Elias Mouchlianitis et al. SCHIZOPHRENIA BULLETIN
- Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes
- (2014) Irma E. Cisneros et al. NEUROPHARMACOLOGY
- Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
- (2014) D. Leo et al. NEUROPHARMACOLOGY
- A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
- (2012) F G Revel et al. MOLECULAR PSYCHIATRY
- A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
- (2012) E. Jaaskelainen et al. SCHIZOPHRENIA BULLETIN
- Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
- (2011) S. Espinoza et al. MOLECULAR PHARMACOLOGY
- TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
- (2011) F. G. Revel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
- (2009) A. Bradaia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More